ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 176 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $354,027,000 | -55.0% | 5,700 | -50.9% | 0.07% | -52.7% |
| Q1 2017 | $786,248,000 | +598.9% | 11,600 | +625.0% | 0.15% | +581.8% |
| Q4 2016 | $112,496,000 | -0.9% | 1,600 | 0.0% | 0.02% | +10.0% |
| Q3 2016 | $113,504,000 | +32.6% | 1,600 | -8.6% | 0.02% | +33.3% |
| Q2 2016 | $85,593,000 | -85.1% | 1,750 | -80.7% | 0.02% | -85.8% |
| Q1 2016 | $572,956,000 | -46.0% | 9,050 | -4.2% | 0.11% | -41.8% |
| Q4 2015 | $1,060,101,000 | +61.9% | 9,450 | +39.0% | 0.18% | +111.6% |
| Q3 2015 | $654,908,000 | -84.4% | 6,800 | -83.4% | 0.09% | -81.5% |
| Q2 2015 | $4,187,751,000 | +64.9% | 40,900 | 0.0% | 0.47% | +65.2% |
| Q1 2015 | $2,539,481,000 | – | 40,900 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |